Workgroup #3: Monitoring effects of treatment for cancer and for benign prostatic hyperplasia.
Jones
G W
GW
Howard University College of Medicine, Washington, DC 20009.
Smith
R A
RA
Batjer
J D
JD
Bostwick
D G
DG
Corn
B W
BW
Guess
H A
HA
Hudson
M A
MA
Kabalin
J
J
Soloway
M S
MS
D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000628:therapy
D017430:Prostate-Specific Antigen